Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Kempharm, Inc.

Initiate the clinical program for KP879

Delivered after the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
27 Jan 2021
Due
30 Jun 2021
Delivered
October 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“initiate the clinical program for KP879 currently planned to begin mid-year 2021”

What we found

Evidence strength A What the grades mean

The company initiated the clinical program for KP879 in October 2021, which was after the mid-year 2021 deadline.

  • A
    Kempharm, Inc. 10-Q filed 2021-08-13 Regulatory filing · published 13 Aug 2021 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint b177039286d7
    “Initiation of Clinical Program - H2 2021” ✓ confirmed on the page
  • A
    Kempharm, Inc. 10-K filed 2022-03-31 Regulatory filing · published 31 Mar 2022 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint e9720a951e31
    “We initiated the clinical program in October 2021” ✓ confirmed on the page

Market reaction: the shares moved -1.7% against the S&P 500 over the three sessions around the disclosure (30 Mar 2022 to 4 Apr 2022). What this measures

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Project other
Indicative materiality
Low rules
Action
Initiate
Deliverable
KP879 clinical program
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Kempharm, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-ZVRA-022493 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.